Pascal Besman, Chief Operating Officer of PharmaMar, talks about Submitting Update of Monotherapy to ESMO | Closure of ATLANTIS Trial in Small Cell at Annual Meeting 2018
Submitting Update of Monotherapy to ESMO | Closure of ATLANTIS Trial in Small Cell
